UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer

Journal of hematology and oncology, 2023-06, Vol.16 (1), p.66-66, Article 66

2023

Volltextzugriff (PDF)

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

Trials, 2019-12, Vol.20 (1), p.753-753, Article 753

2019

Volltextzugriff (PDF)

EAL Writers and Peer Tutors: Pedagogies that Resist the “Broken Writer” Myth

Discourse and writing/rédactologie, 2019-12, Vol.29

2019

Volltextzugriff (PDF)

Report from the Relaunch of the CJSDW/R

Discourse and writing/rédactologie, 2017-03, Vol.27, p.9-12

Goldrick-Jones, Amanda

2017

Volltextzugriff (PDF)

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

Journal of clinical oncology, 2023-06, Vol.41 (16), p.2893-2903

2023

Volltextzugriff (PDF)

Poster: MM-146 Using Data Science to Characterize Patterns in Cardiovascular Clinical Data: Topological Analysis of Baseline Characteristics in Patients With Relapsed/Refractory Multiple Myeloma Enrolled in Carfilzomib Trials

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S179

2022

Volltextzugriff (PDF)

MM-146 Using Data Science to Characterize Patterns in Cardiovascular Clinical Data: Topological Analysis of Baseline Characteristics in Patients With Relapsed/Refractory Multiple Myeloma Enrolled in Carfilzomib Trials

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S407-S408

2022

Volltextzugriff (PDF)

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis of the Phase 3 Candor Study in Patients with Early or Late Relapse

Blood, 2020-11, Vol.136 (Supplement 1), p.37-38

2020

Volltextzugriff (PDF)

Safety and efficacy of once-weekly carfilzomib (K) dosing in frail patients (pts): A subgroup analysis from the phase 3 A.R.R.O.W. study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8027-8027

2019

Volltextzugriff (PDF)

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures

Asia-Pacific journal of clinical oncology, 2017-08, Vol.13 (4), p.266-276

2017

Volltextzugriff (PDF)

Safety and efficacy of once-weekly carfilzomib (K) dosing in frail patients (pts): a subgroup analysis from the phase 3 A.R.R.O.W. study

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e31-e32

2019

Volltextzugriff (PDF)

Trial in Progress: Once-Weekly vs Twice-Weekly Dosing of Carfilzomib-Lenalidomide-Dexamethasone in Patients w/ Relapsed or Refractory Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e266-e267

2019

Volltextzugriff (PDF)

Trial in Progress: Once-Weekly vs Twice-Weekly Carfilzomib (K) Dosing in Combination with Lenalidomide (R) and Dexamethasone (d) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S332-S333

2019

Volltextzugriff (PDF)

Safety and Efficacy of Once-Weekly Carfilzomib (K) Dosing in Frail Patients (pts): A Subgroup Analysis from the Phase 3 A.R.R.O.W. Study

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S320-S321

2019

Volltextzugriff (PDF)

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand

Trials, 2019-12, Vol.20 (1)

2019

Volltextzugriff (PDF)

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Blood advances, 2020-11, Vol.4 (21), p.5449-5459

2020

Volltextzugriff (PDF)

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures: Denosumab: rare toxicities

Asia-Pacific journal of clinical oncology, 2017-08, Vol.13 (4), p.266-276

2017

Volltextzugriff (PDF)

Severe Symptomatic Hypocalcaemia Following High-Dose Oral Ibandronate in a Patient With Prior Thyroidectomy and Metastatic Bone Disease

Journal of endocrinology and metabolism, 2012-04

Chen

2012

Volltextzugriff (PDF)

The critical eye, the gendered lens, and "situated"; insights-feminist contributions to professional communication

Technical communication quarterly, 1994-06, Vol.3 (3), p.245-256

1994

Volltextzugriff (PDF)

The Ribbon and the Rose : Visual Rhetorics Against Violence to Women

Ethnologies (Québec), 2004-01, Vol.26 (1), p.95-123

Goldrick-Jones, Amanda

2004

Volltextzugriff (PDF)

Men and Feminism: Relationships and Differences

Gender, Race, and Nation, 2016, p.184-204

Goldrick-Jones, Amanda

2016

Volltextzugriff (PDF)

Pessimism, Paralysis, and Possibility: Crisis-Points in Profeminism

The Journal of men's studies, 2001-03, Vol.9 (3), p.323-339

Goldrick-Jones, Amanda

2001

Volltextzugriff (PDF)

Gender, race, and nation: a global perspective

Gender, race, and nation, 2002, p.x-x

1, 2002

Volltextzugriff (PDF)

Men and Feminism: Relationships and Differences

Gender, Race, and Nation, 2002, p.184

Amanda Goldrick-Jones

2002

Volltextzugriff (PDF)

Men in a feminist forum: A rhetorical analysis of the White Ribbon Campaign against male violence

Goldrick-Jones, Amanda

1996

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

EAL Writers and Peer Tutors: Pedagogies that Resist the “Broken Writer” Myth

Report from the Relaunch of the CJSDW/R

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

Poster: MM-146 Using Data Science to Characterize Patterns in Cardiovascular Clinical Data: Topological Analysis of Baseline Characteristics in Patients With Relapsed/Refractory Multiple Myeloma Enrolled in Carfilzomib Trials

MM-146 Using Data Science to Characterize Patterns in Cardiovascular Clinical Data: Topological Analysis of Baseline Characteristics in Patients With Relapsed/Refractory Multiple Myeloma Enrolled in Carfilzomib Trials

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis of the Phase 3 Candor Study in Patients with Early or Late Relapse

Safety and efficacy of once-weekly carfilzomib (K) dosing in frail patients (pts): A subgroup analysis from the phase 3 A.R.R.O.W. study

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures

Safety and efficacy of once-weekly carfilzomib (K) dosing in frail patients (pts): a subgroup analysis from the phase 3 A.R.R.O.W. study

Trial in Progress: Once-Weekly vs Twice-Weekly Dosing of Carfilzomib-Lenalidomide-Dexamethasone in Patients w/ Relapsed or Refractory Multiple Myeloma

Trial in Progress: Once-Weekly vs Twice-Weekly Carfilzomib (K) Dosing in Combination with Lenalidomide (R) and Dexamethasone (d) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Safety and Efficacy of Once-Weekly Carfilzomib (K) Dosing in Frail Patients (pts): A Subgroup Analysis from the Phase 3 A.R.R.O.W. Study

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures: Denosumab: rare toxicities

Severe Symptomatic Hypocalcaemia Following High-Dose Oral Ibandronate in a Patient With Prior Thyroidectomy and Metastatic Bone Disease

The critical eye, the gendered lens, and "situated"; insights-feminist contributions to professional communication

The Ribbon and the Rose : Visual Rhetorics Against Violence to Women

Men and Feminism: Relationships and Differences

Pessimism, Paralysis, and Possibility: Crisis-Points in Profeminism

Gender, race, and nation: a global perspective

Men and Feminism: Relationships and Differences

Men in a feminist forum: A rhetorical analysis of the White Ribbon Campaign against male violence

Suchergebnisse filtern